Bin Zheng, PhD, who specializes in targeted therapies and immunotherapy, was appointed director of melanoma research in the Department of Biomedical Sciences at Los Angeles-based Cedars-Sinai Cancer.
The Latest
A growing body of research shows cancer rates are on the rise in adults younger than 50. In response, many oncologists have pointed to the need for more awareness across the healthcare continuum, stronger care coordination on the primary care…
Houston-based University of Texas MD Anderson Cancer Center has partnered with CureVac, a global biopharmaceutical company, to develop novel mRNA-based cancer vaccines.
Medicare reimbursement for common breast cancer surgeries have declined significantly over the last 20 years, a new study from researchers at the Fox Chase Cancer Center and Temple University Hospital, both based in Philadelphia, found.
Eighteen percent of oncologists said their burnout is so severe that they may leave medicine, according to a Medscape report.
Columbus-based Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital found that the "concerning rise" in nonsmoking lung cancer cases could be due to radon gas.
St. Mary's Health System will close its oncology practice, St. Mary's Center For Cancer and Blood Disorders, on July 1, ABC affiliate WMTW reported April 12.
Cancer patients participating in treatment trials is twice as high than historical estimates, a recent study found.
Cleveland Clinic Cancer Institute is partnering with Egg Harbor Township, N.J.-based AtlantiCare Cancer Institute to expand access to advanced research, clinical trials and cancer treatment for AtlantiCare patients.
The funding bill for the National Cancer Institute and the National Institutes of Health have been finalized, leaving the NCI with $96 million less than its fiscal year 2023 total enacted budget but $120 million more compared to the base…